Reviva Pharmaceuticals Holdings, Inc. Common Stock (RVPH)

$0.36 -55.68%
EARNINGS ANALYTICS
event_upcoming Est. Next Earnings: 2026-08-14 ESTIMATED
search

Reviva Pharmaceuticals Holdings, Inc. Common Stock (RVPH) has reported earnings 18 times since Aug 16, 2021. The stock moves an average of ±8.58% the day after reporting, closing higher 50.0% of the time. Its largest post-earnings gain was +15.9% (Aug 14, 2025) and its largest decline was -35.63% (Mar 31, 2025). The next earnings report is predicted for 2026-08-14 (estimated).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

18

Avg Abs. Movement

±8.58%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date Timing Open High Close Volume Movement % SEC Filing
May 13, 2026 ☽ POST $0.33 $0.44 $0.36 117,720 +0% open_in_new
Mar 30, 2026 ☀ PRE $0.69 $0.69 $0.66 23,648 -10.58% open_in_new
Nov 13, 2025 ☽ POST $0.56 $0.56 $0.54 7,096 -7.41% open_in_new
Aug 14, 2025 ☽ POST $0.47 $0.47 $0.47 8,590 +15.9% open_in_new
May 15, 2025 ☽ POST $0.83 $0.84 $0.83 1,544 +0.16% open_in_new
Mar 31, 2025 ☽ POST $1.00 $1.00 $0.96 10,489 -35.63% open_in_new
Nov 14, 2024 ☽ POST $1.25 $1.27 $1.21 4,205 -7.44% open_in_new
Aug 14, 2024 ☀ PRE $0.70 $0.74 $0.71 7,991 +3.17% open_in_new
May 14, 2024 ☀ PRE $1.68 $1.83 $1.83 19,346 +7.62% open_in_new
Nov 14, 2023 ☽ POST $5.96 $5.96 $5.50 12,600 -9.09% open_in_new
Aug 14, 2023 ☽ POST $3.95 $4.20 $4.18 1,929 +2.63% open_in_new
May 15, 2023 ☽ POST $7.32 $8.22 $7.96 1,571 -1.76% open_in_new
Mar 30, 2023 ☀ PRE $4.52 $4.61 $4.37 7,062 -7.42% open_in_new
Nov 14, 2022 ☽ POST $5.12 $5.47 $4.95 6,510 -19.8% open_in_new
Aug 15, 2022 ☽ POST $0.78 $0.78 $0.78 120 -7.43% open_in_new
May 16, 2022 ☽ POST $1.51 $1.51 $1.51 100 +12.25% open_in_new
Mar 15, 2022 ☽ POST $1.84 $1.86 $1.74 1,419 +0.57% open_in_new
Aug 16, 2021 ☀ PRE $3.61 $3.64 $3.64 200 +5.51% open_in_new
event

Earnings Count

18

Total earnings in dataset

trending_up

Avg Abs. Movement

±8.58%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

Recent SEC Filings

5 most recent
Form Date Filed View on EDGAR
SCHEDULE 13G/A 20260515 open_in_new SEC.gov
SCHEDULE 13G 20260514 open_in_new SEC.gov
10-Q 20260513 open_in_new SEC.gov
8-K 20260513 open_in_new SEC.gov
8-K 20260513 open_in_new SEC.gov

Frequently asked about RVPH earnings

When does Reviva Pharmaceuticals Holdings, Inc. Common Stock report earnings next? expand_more

Reviva Pharmaceuticals Holdings, Inc. Common Stock (RVPH)'s next earnings date is estimated for 2026-08-14. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does RVPH stock move after earnings? expand_more

Over 18 reports, RVPH has moved an average of ±8.58% the session after earnings, closing higher 50.0% of the time.

What was RVPH's biggest post-earnings move? expand_more

RVPH's largest post-earnings gain on record was +15.9% on Aug 14, 2025, and its largest decline was -35.63% on Mar 31, 2025.

Where can I find Reviva Pharmaceuticals Holdings, Inc. Common Stock's SEC filings? expand_more

All of Reviva Pharmaceuticals Holdings, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers